AKT1 and breast cancer: This context dependency may explain why, despite CD147’s ubiquitous involvement, downstream signaling varies—such as enhanced PI3K/Akt activity in NSCLC (56), heightened MAPK/ERK sensitivity in BC (28), or Wnt/β-catenin predominance in certain epithelial malignancies (62).